Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...
All the companies have skin in the game for clotting/bleeding disorders. The BMS-Pfizer Alliance market Factor Xa blood ...
In less than a month, Americans will head to the polls—or vote by mail—and elect the next president of the U.S. | While a ...
Earlier this year, Evonik unveiled a restructuring project that will result in up to 2,000 layoffs. | After Evonik in March ...
Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pf | For the second time in six months, the FDA ...
As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a ...
The survey suggests ads can improve health management. Almost half of patients said ads help them make informed decisions ...
A new campaign from Opella, Sanofi’s consumer health unit, is a royal flush. | A new campaign from Opella, Sanofi’s consumer ...
Lilly has earmarked $200 million for the upgrade, a company spokesperson confirmed to Fierce Pharma. The new project will ...
Thermo Fisher Scientific is responsible for helping to produce some of the hottest drugs on the market, including Novo ...
With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a ...
The agreement frees the British pharma giant from litigating 93% of the state court cases it faced in the U.S.